Hospitals are generally supportive of the latest effort by Senate lawmakers to clarify Congress’ intent and operational requirements for the 340B drug discount program, especially aspects of draft legislation that may deter drug companies from imposing restrictions on how participating hospitals use contract pharmacies to dispense discounted drugs, and curb anticompetitive and discriminatory practices employed by insurers and pharmacy benefit managers. But hospitals are unenthusiastic about language in the draft legislation that would solidify a new definition of what constitutes...